Jan‐Åke Liljeqvist

2.3k total citations
65 papers, 1.7k citations indexed

About

Jan‐Åke Liljeqvist is a scholar working on Epidemiology, Immunology and Virology. According to data from OpenAlex, Jan‐Åke Liljeqvist has authored 65 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Epidemiology, 24 papers in Immunology and 17 papers in Virology. Recurrent topics in Jan‐Åke Liljeqvist's work include Herpesvirus Infections and Treatments (39 papers), Poxvirus research and outbreaks (16 papers) and Cytomegalovirus and herpesvirus research (11 papers). Jan‐Åke Liljeqvist is often cited by papers focused on Herpesvirus Infections and Treatments (39 papers), Poxvirus research and outbreaks (16 papers) and Cytomegalovirus and herpesvirus research (11 papers). Jan‐Åke Liljeqvist collaborates with scholars based in Sweden, United States and France. Jan‐Åke Liljeqvist's co-authors include Tomas Bergström, Peter Norberg, Bo Svennerholm, Edward Trybala, Magnus Lindh, Johan Hoebeke, Petra Tunbäck, Finn Waagstein, Å Hjalmarson and Ylva Magnusson and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Jan‐Åke Liljeqvist

64 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan‐Åke Liljeqvist Sweden 25 974 328 312 308 295 65 1.7k
Fabian Wild France 20 834 0.9× 528 1.6× 101 0.3× 297 1.0× 351 1.2× 49 1.5k
Bracha Rager‐Zisman Israel 24 746 0.8× 741 2.3× 186 0.6× 253 0.8× 540 1.8× 82 1.8k
Shudo Yamazaki Japan 27 765 0.8× 367 1.1× 475 1.5× 348 1.1× 907 3.1× 84 1.9k
Arno C. Andeweg Netherlands 27 841 0.9× 608 1.9× 79 0.3× 345 1.1× 951 3.2× 54 2.1k
Michael Huber Switzerland 27 517 0.5× 746 2.3× 248 0.8× 673 2.2× 829 2.8× 76 2.5k
Geoffrey Shellam Australia 25 1.1k 1.1× 961 2.9× 238 0.8× 184 0.6× 219 0.7× 57 2.0k
M Bendinelli Italy 21 1.0k 1.0× 318 1.0× 133 0.4× 203 0.7× 327 1.1× 101 1.7k
Tracy J. Ruckwardt United States 25 792 0.8× 651 2.0× 54 0.2× 375 1.2× 431 1.5× 51 1.6k
Judy A. Beeler United States 32 2.1k 2.2× 723 2.2× 99 0.3× 203 0.7× 1.0k 3.5× 60 2.9k
Carlos López United States 21 1.6k 1.6× 360 1.1× 62 0.2× 347 1.1× 629 2.1× 53 2.6k

Countries citing papers authored by Jan‐Åke Liljeqvist

Since Specialization
Citations

This map shows the geographic impact of Jan‐Åke Liljeqvist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan‐Åke Liljeqvist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan‐Åke Liljeqvist more than expected).

Fields of papers citing papers by Jan‐Åke Liljeqvist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan‐Åke Liljeqvist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan‐Åke Liljeqvist. The network helps show where Jan‐Åke Liljeqvist may publish in the future.

Co-authorship network of co-authors of Jan‐Åke Liljeqvist

This figure shows the co-authorship network connecting the top 25 collaborators of Jan‐Åke Liljeqvist. A scholar is included among the top collaborators of Jan‐Åke Liljeqvist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan‐Åke Liljeqvist. Jan‐Åke Liljeqvist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zur‐Mühlen, Bengt von, Bo‐Göran Ericzon, Carin Wallquist, et al.. (2021). COVID-19 in solid organ transplant recipients: A national cohort study from Sweden. American Journal of Transplantation. 21(8). 2762–2773. 27 indexed citations
2.
Marklund, Emelie, Susannah Leach, Kristina Nystrôm, et al.. (2021). Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4+ T-Cell Responses. Frontiers in Immunology. 12. 750448–750448. 9 indexed citations
3.
Gisslén, Magnus, Jan‐Åke Liljeqvist, Vanda Friman, et al.. (2021). Longevity of anti-spike and anti-nucleocapsid antibodies after COVID-19 in solid organ transplant recipients compared to immunocompetent controls. American Journal of Transplantation. 22(4). 1245–1252. 13 indexed citations
4.
Sundell, Nicklas, Leif Dotevall, Maria Andersson, et al.. (2019). Measles outbreak in Gothenburg urban area, Sweden, 2017 to 2018: low viral load in breakthrough infections. Eurosurveillance. 24(17). 39 indexed citations
5.
Nilsson, Malin S., Karin Christenson, Ebru Aydin, et al.. (2018). Cytomegalovirus Serostatus Affects Autoreactive NK Cells and Outcomes of IL2-Based Immunotherapy in Acute Myeloid Leukemia. Cancer Immunology Research. 6(9). 1110–1119. 8 indexed citations
6.
Tang, Ka‐Wei, et al.. (2014). Rad51 and Rad52 Are Involved in Homologous Recombination of Replicating Herpes Simplex Virus DNA. PLoS ONE. 9(11). e111584–e111584. 5 indexed citations
7.
Schepis, Danika, Kristina Træholt Franck, Petra Jones, et al.. (2011). Increased Cell-Mediated Immune Responses in Patients with Recurrent Herpes Simplex Virus Type 2 Meningitis. Clinical and Vaccine Immunology. 18(4). 655–660. 13 indexed citations
8.
Adamiak, Beata, Edward Trybala, Maria E. Johansson, et al.. (2010). Human antibodies to herpes simplex virus type 1 glycoprotein C are neutralizing and target the heparan sulfate-binding domain. Virology. 400(2). 197–206. 20 indexed citations
9.
Lagergård, Teresa, et al.. (2008). Seroprevalences of Herpes Simplex Virus Type 2, Five Oncogenic Human Papillomaviruses, and Chlamydia trachomatis in Katowice, Poland. Clinical and Vaccine Immunology. 15(4). 675–680. 6 indexed citations
10.
Tolf, Conny, Jens‐Ola Ekström, Maria Gullberg, et al.. (2008). Characterization of polyclonal antibodies against the capsid proteins of Ljungan virus. Journal of Virological Methods. 150(1-2). 34–40. 16 indexed citations
11.
Norberg, Peter, Mabula Kasubi, Lars Haarr, Tomas Bergström, & Jan‐Åke Liljeqvist. (2007). Divergence and Recombination of Clinical Herpes Simplex Virus Type 2 Isolates. Journal of Virology. 81(23). 13158–13167. 60 indexed citations
12.
13.
Viscidi, Raphael P., Eligius Lyamuya, Fred Mhalu, et al.. (2006). Prevalence of serum antibodies to human papilloma virus in patients with genital ulcer disease in an urban population of Tanzania. Sexually Transmitted Infections. 83(1). 64–65. 4 indexed citations
14.
Bellner, Lars, Fredrik B. Thorén, Erik Nygren, et al.. (2005). A Proinflammatory Peptide from Herpes Simplex Virus Type 2 Glycoprotein G Affects Neutrophil, Monocyte, and NK Cell Functions. The Journal of Immunology. 174(4). 2235–2241. 51 indexed citations
15.
Liljeqvist, Jan‐Åke, Edward Trybala, Johan Hoebeke, Bo Svennerholm, & Tomas Bergström. (2002). Monoclonal antibodies and human sera directed to the secreted glycoprotein G of herpes simplex virus type 2 recognize type-specific antigenic determinants. Journal of General Virology. 83(1). 157–165. 24 indexed citations
16.
Trybala, Edward, et al.. (2002). Glycosaminoglycan-Binding Ability Is a Feature of Wild-Type Strains of Herpes Simplex Virus Type 1. Virology. 302(2). 413–419. 26 indexed citations
17.
Trybala, Edward, Jan‐Åke Liljeqvist, Bo Svennerholm, & Tomas Bergström. (2000). Herpes Simplex Virus Types 1 and 2 Differ in Their Interaction with Heparan Sulfate. Journal of Virology. 74(19). 9106–9114. 113 indexed citations
18.
Karlson, B. W., Johan Herlitz, Per Hallgren, et al.. (1994). Emergency room prediction of mortality and severe complications in patients with suspected acute myocardial infarction. European Heart Journal. 15(11). 1558–1565. 16 indexed citations
19.
Herlitz, Johan, Björn W. Karlson, Per Pettersson, et al.. (1992). Risk factors for death and mode of death after acute myocardial infarction in relation to age. Coronary Artery Disease. 3(11). 1055–1064. 3 indexed citations
20.
Liljeqvist, Jan‐Åke & Nils Edvardsson. (1989). Torsade de Pointes Tachycardias Induced by Overdosage of Zimeldine. Journal of Cardiovascular Pharmacology. 14(4). 666–670. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabian Wild Breakdown of academic impact, for papers by Bracha Rager‐Zisman Breakdown of academic impact, for papers by Shudo Yamazaki Breakdown of academic impact, for papers by Arno C. Andeweg Breakdown of academic impact, for papers by Michael Huber Breakdown of academic impact, for papers by Geoffrey Shellam Breakdown of academic impact, for papers by M Bendinelli Breakdown of academic impact, for papers by Tracy J. Ruckwardt Breakdown of academic impact, for papers by Judy A. Beeler Breakdown of academic impact, for papers by Carlos López
Rankless by CCL
2026